Document is current
Any future updates will be listed below
-
Authors
Caplunik-Pratsch, Aila
Kieninger, Bärbel
Hansch, Stefan
Rath, Anca
Fritsch, Jürgen
Eichner, Anja
Hanses, Frank
Schneider-Brachert, Wulf
Hitzenbichler, Florian
-
Funding
Funding for this research was provided by:
Universitätsklinikum Regensburg
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 14 November 2025
First Online: 28 November 2025
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the University of Regensburg (approval number 22–3027-104; date: February 8, 2022). The Ethics Committee granted a waiver for patient consent due to the retrospective study design.
: Not applicable.
: SH: travel grants from Gilead Sciences; AR: Payment of honoraria and transportation for lectures for the Bavarian Health and Food Safety Authority; FHa: Grants from Bavarian State Ministry for Health and Care for a post-covid outpatient treatment center; grants from Federal Ministry of Education and Research for a network in university medicine; lecture fees and honoraria from the German Society for Interdisciplinary Emergency and Acute Medicine, academy for infection medicine, Bavarian State Medical Association and Correvio/Advanz; participation in the advisory board of Sobi, GSK; FHi: Lecture fees from Pfizer pharma and MSD Sharp & Dohme; travel grants and congress fees from Gilead Sciences and Tillotts Pharma.
